These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25196154)

  • 1. Understanding antihypertensive medication use after living kidney donation through linked national registry and pharmacy claims data.
    Lentine KL; Schnitzler MA; Garg AX; Xiao H; Axelrod D; Tuttle-Newhall JE; Brennan DC; Segev DL
    Am J Nephrol; 2014; 40(2):174-83. PubMed ID: 25196154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gout after living kidney donation: correlations with demographic traits and renal complications.
    Lam NN; Garg AX; Segev DL; Schnitzler MA; Xiao H; Axelrod D; Brennan DC; Kasiske BL; Tuttle-Newhall JE; Lentine KL
    Am J Nephrol; 2015; 41(3):231-40. PubMed ID: 25896309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors.
    Lentine KL; Schnitzler MA; Xiao H; Axelrod D; Garg AX; Tuttle-Newhall JE; Brennan DC; Segev DL
    Transplantation; 2014 Feb; 97(3):316-24. PubMed ID: 24192712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in use of prescription narcotic medications among living kidney donors.
    Lentine KL; Lam NN; Schnitzler MA; Garg AX; Xiao H; Leander SE; Brennan DC; Taler SJ; Axelrod D; Segev DL
    Clin Transplant; 2015 Oct; 29(10):927-37. PubMed ID: 26227016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impacts of center and clinical factors in antihypertensive medication use after kidney transplantation.
    Koraishy FM; Yamout H; Naik AS; Zhang Z; Schnitzler MA; Ouseph R; Lam NN; Dharnidharka VR; Axelrod D; Hess GP; Segev DL; Kasiske BL; Lentine KL
    Clin Transplant; 2020 Mar; 34(3):e13803. PubMed ID: 31997429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race, Relationship and Renal Diagnoses After Living Kidney Donation.
    Lentine KL; Schnitzler MA; Garg AX; Xiao H; Axelrod D; Tuttle-Newhall JE; Brennan DC; Segev DL
    Transplantation; 2015 Aug; 99(8):1723-9. PubMed ID: 25905980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial variation in medical outcomes among living kidney donors.
    Lentine KL; Schnitzler MA; Xiao H; Saab G; Salvalaggio PR; Axelrod D; Davis CL; Abbott KC; Brennan DC
    N Engl J Med; 2010 Aug; 363(8):724-32. PubMed ID: 20818874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of obesity with antidiabetic medication use after living kidney donation: An analysis of linked national registry and pharmacy fill records.
    Lentine KL; Koraishy FM; Sarabu N; Naik AS; Lam NN; Garg AX; Axelrod D; Zhang Z; Hess GP; Kasiske BL; Segev DL; Henderson ML; Massie AB; Holscher CM; Schnitzler MA
    Clin Transplant; 2019 Oct; 33(10):e13696. PubMed ID: 31421057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
    Colvin CL; King JB; Oparil S; Wright JT; Ogedegbe G; Mohanty A; Hardy ST; Huang L; Hess R; Muntner P; Bress A
    JAMA Netw Open; 2020 Nov; 3(11):e2025127. PubMed ID: 33206191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health outcomes among non-Caucasian living kidney donors: knowns and unknowns.
    Lentine KL; Segev DL
    Transpl Int; 2013 Sep; 26(9):853-64. PubMed ID: 23531054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sex-specific antihypertensive drug therapy].
    Pühringer P; Gouya G; Reichardt B; Wolzt M
    Wien Med Wochenschr; 2006 Sep; 156(17-18):498-500. PubMed ID: 17041806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between birth weight and antihypertensive medication in black and white medicaid recipients.
    Lackland DT; Egan BM; Syddall HE; Barker DJ
    Hypertension; 2002 Jan; 39(1):179-83. PubMed ID: 11799099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription patterns of opioids and non-steroidal anti-inflammatory drugs in the first year after living kidney donation: An analysis of U.S. Registry and Pharmacy fill records.
    Vest LS; Sarabu N; Koraishy FM; Nguyen MT; Park M; Lam NN; Schnitzler MA; Axelrod D; Hsu CY; Garg AX; Segev DL; Massie AB; Hess GP; Kasiske BL; Lentine KL
    Clin Transplant; 2020 Aug; 34(8):e14000. PubMed ID: 32502285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of Antihypertensive Medication Consumption and Drug-Drug Interaction with Statin and Metformin with Reduced Alzheimer's Disease and Related Dementias Risk among Hypertensive Patients with Mild Cognitive Impairment using High Volume Claims Data.
    Lundin SK; Hu X; Feng J; Lundin KK; Chen Y; Tao C
    Res Sq; 2023 Apr; ():. PubMed ID: 37090575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression diagnoses after living kidney donation: linking U.S. Registry data and administrative claims.
    Lentine KL; Schnitzler MA; Xiao H; Axelrod D; Davis CL; McCabe M; Brennan DC; Leander S; Garg AX; Waterman AD
    Transplantation; 2012 Jul; 94(1):77-83. PubMed ID: 22691958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive medication exposure and cardiovascular outcomes in hemodialysis patients.
    Shireman TI; Phadnis MA; Wetmore JB; Zhou X; Rigler SK; Spertus JA; Ellerbeck EF; Mahnken JD
    Am J Nephrol; 2014; 40(2):113-22. PubMed ID: 25139551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How well have practices followed guidelines in prescribing antihypertensive drugs: the role of health insurance.
    Guo JD; Liu GG; Christensen DB; Fu AZ
    Value Health; 2003; 6(1):18-28. PubMed ID: 12535235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes Mellitus in Living Pancreas Donors: Use of Integrated National Registry and Pharmacy Claims Data to Characterize Donation-Related Health Outcomes.
    Lam NN; Schnitzler MA; Segev DL; Hess GP; Kasiske BL; Randall HB; Axelrod D; Xiao H; Garg AX; Brennan DC; Lentine KL
    Transplantation; 2017 Jun; 101(6):1276-1281. PubMed ID: 27482962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of hypertension treatment in Belgium, a pharmacoepidemiological study.
    Wolf M; Heuten HG; De Swaef A; de Falleur M; Verpooten GA
    Acta Cardiol; 2012 Apr; 67(2):147-52. PubMed ID: 22641971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition from donor candidates to live kidney donors: the impact of race and undiagnosed medical disease states.
    Norman SP; Song PX; Hu Y; Ojo AO
    Clin Transplant; 2011; 25(1):136-45. PubMed ID: 20047616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.